VRTX

Vertex Pharmaceuticals Inc

Price:

468.00

USD

Volume:

1,090,351.00

United States | Biotechnology

-110.04 %

Upside

As of 2024-09-09, the Fair Value of Vertex Pharmaceuticals Inc (VRTX) is -46.96 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 468.00 USD, the upside of Vertex Pharmaceuticals Inc is -110.04%.

Note: valuation result may not be accurate due to the company's negative EPS.

468.00 USD

Stock Price

-46.96 USD

Fair Price

Peter Lynch's formula is:

Vertex Fair Value

= Earnings Growth Rate x TTM EPS
Vertex Fair Value

= 24.74 x -1.90
Vertex Fair Value

= -46.96
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |

Net income | 1,176.80 | 2,711.60 | 2,342.10 | 3,322.00 | 3,619.60 | 2,634.42 |

YoY growth | -43.88% | 130.42% | -13.63% | 41.84% | 8.96% | 24.74% |

Market Cap (mil) | 120,790.80 |

P/E | |

Forward P/E | 29.39x |

EPS | -1.90 |

Avg earnings growth rate | 24.74% |

TTM earnings | -489.90 |